GlassScriptPhysician profile
Guillermo Salinas
NPI 1215065529
$23,540.29
in general payments reported to CMS, 2019-2025
27 companies · $2,650 in 2025
The $2,650 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,770 · 2020: $394 · 2021: $1,448 · 2022: $8,120 · 2023: $2,784 · 2024: $3,375 · 2025: $2,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,515 · Travel and Lodging: $4,293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,514.94 |
| Travel and Lodging | $4,293.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $7,530.33 | 2020-2023 | |
| Edwards Lifesciences Corporation | $3,645.50 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abbott Laboratories | $3,150.51 | 2019-2024 | Amplatzer Amulet, Perclose Proglide, Jeti Peripheral Catheter |
| Medtronic Vascular, INC. | $2,590.55 | 2019-2020 | |
| Boston Scientific Corporation | $2,450.20 | 2019-2025 | General - Vascular Access, General - Interventional Oncology |
| Medtronic, INC. | $1,334.50 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Abiomed | $796.07 | 2023-2025 | Impella |
| Heartflow, INC. | $273.65 | 2022-2024 | |
| Shockwave Medical, INC | $267.24 | 2021-2025 | |
| Silk Road Medical, INC. | $224.83 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cardiovascular Systems INC. | $183.30 | 2019-2022 | |
| Corindus INC. | $169.52 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $159.16 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $145.20 | 2022-2024 | |
| Acist Medical Systems, INC. | $120.34 | 2021-2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $115.43 | 2025 | Wegovy |
| Gilead Sciences, INC. | $73.09 | 2019 | |
| Philips North America LLC | $60.25 | 2023 | |
| Pfizer INC. | $47.81 | 2021-2024 | |
| Bard Peripheral Vascular, INC. | $46.61 | 2025 | Fluency Endovascular Stent Graft |
| Impulse Dynamics (USA) INC. | $45.52 | 2023 | Optimizer |
| Amgen INC. | $35.66 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $25.83 | 2022-2024 | Eliquis |
| Preventice Services, LLC | $18.68 | 2021 | |
| Cardiva Medical, INC. | $16.51 | 2022 | |
| Atricure, INC. | $14.00 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guillermo Salinas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.